Impax Laboratories, Inc. announced a voluntary nationwide retail level recall of one lot of Lamotrigine Orally Disintegrating Tablet (ODT) 200 mg.
Unit-of-use blister packs may contain 100 mg product instead of 200 mg product. Each blister card within the unit-of-use blister pack is properly labeled as 100 mg ODT, however the plastic shell pack containing the 100 mg blister cards is labeled as 200 mg ODT. Shell-packs from the affected lot may contain 100 mg ODT instead of 200 mg ODT, and as a result, it is possible that consumers could take less than their intended lamotrigine dose. See the FDA website for more information about this recall.